Times Square Capital Management, LLC Repligen Corp Transaction History
Times Square Capital Management, LLC
- $6.51 Billion
- Q4 2024
A detailed history of Times Square Capital Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Times Square Capital Management, LLC holds 260,992 shares of RGEN stock, worth $39.3 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
260,992
Previous 275,627
5.31%
Holding current value
$39.3 Million
Previous $41 Million
8.41%
% of portfolio
0.58%
Previous 0.63%
Shares
15 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.07 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$768 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$255 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$232 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.36B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....